Alvotech (ALVO) Intangibles (2020 - 2026)
Alvotech's (ALVO) quarterly Intangibles came in at $142.5 million in Q2 2026, up 160.53% on a YoY basis from $54.7 million in Q2 2025, and up 19.13% quarter-over-quarter from $119.6 million in Q1 2026.
Analysis
Alvotech (ALVO) Intangibles (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Intangibles for 7 consecutive years, with $142.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Intangibles rose 160.53% year-over-year to $142.5 million; the trailing twelve-month figure through Jun 2026 stood at $142.5 million (up 160.53% YoY), and the FY2025 full-year result was $81.8 million, up 296.85% from the prior year.
- Intangibles advanced to $142.5 million in Q2 2026 per ALVO's latest filing, from $119.6 million in the prior quarter.
- Across five years, Intangibles topped out at $142.5 million in Q2 2026 and bottomed at $14.0 million in Q2 2023.
- Historically, Intangibles has averaged $46.0 million across 5 years, with a median of $22.2 million in 2022.
- The sharpest annual moves came in 2023 and 2026: Intangibles slumped 38.72% in 2023, then jumped 455.24% in 2026.
- Over 5 years, Intangibles stood at $25.7 million in 2022, then retreated by 25.64% to $19.1 million in 2023, then gained by 8.1% to $20.6 million in 2024, then jumped by 296.85% to $81.8 million in 2025, then surged by 74.1% to $142.5 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $142.5 million, $119.6 million, and $81.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 3.45 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 13.68 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 1.09 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 587.83 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 4.18 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 142.48 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 449.86 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 29.23 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 5.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142.48 Mn |
| Mar 31, 2026 | 119.59 Mn |
| Dec 31, 2025 | 81.83 Mn |
| Sep 30, 2025 | 61.87 Mn |
| Jun 30, 2025 | 54.69 Mn |
| Mar 31, 2025 | 21.54 Mn |
| Dec 31, 2024 | 20.62 Mn |
| Sep 30, 2024 | 20.54 Mn |
| Jun 30, 2024 | 19.90 Mn |
| Mar 31, 2024 | 19.37 Mn |
| Dec 31, 2023 | 19.08 Mn |
| Jun 30, 2023 | 14.01 Mn |
| Dec 31, 2022 | 25.65 Mn |
| Jun 30, 2022 | 22.86 Mn |
| Dec 31, 2021 | 21.51 Mn |
| Dec 31, 2020 | 6.34 Mn |